Addressing gender disparities in real estate could unlock significant economic benefits, boosting productivity, innovation, ...
Turntide's advanced electrification solutions will debut at the Bharat Mobility Global Expo 2025 - The Components Show in New Delhi, from January 18-21. This event provides an opportunity for Indian ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, today announced that Roche (SIX: RO, ROG; OTCQX: RHHBY) has exercised its ...
New agreement enables both companies to fuel a broad and innovative pipeline of 212Pb-Radio-DARPin candidates, bringing the total number of ...
SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell ...
10, 2025 (GLOBE NEWSWIRE ... through sophisticated cell therapy design and engineering, starting with CRG-023 and now with our novel allogenic platform that is intended to address immune-based ...
Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.
By incorporating Syenex’s advanced systems into our retroviral and lentiviral vector manufacturing platforms ... Leveraging the power of synthetic biology, we design scalable, precision-engineered ...
The first Vendée Globe skippers should cross the finish line in Les Sables d’Olonne in mid-January. Current ETAs show a new record time is expected for this 10th edition, with the winner finishing ...
LAS VEGAS, NV / / January 6, 2025 / QNX, a division of BlackBerry Limited (NYSE:BB) (TSX:BB), Vector and TTTech Auto today announced a multi-year, global undertaking to collaborate, develop and ...
A sex worker from Brooklyn meets and marries the son of a Russian oligarch. However, her Cinderella-esque story is threatened as her new in-laws set to get the marriage annulled. A visionary ...
Rocket’s innovative multi-platform approach allows us to design the optimal gene therapy ... Rocket’s lentiviral (LV) vector-based hematology portfolio consists of late-stage programs for ...